Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-07-16
1992-03-03
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514185, 514 2, A61K 31555, A01N 5502, C22C 1400
Patent
active
050933272
ABSTRACT:
There are disclosed pharmaceutical compositions containing polyoxoanions, methods of using them alone or in combination with other compounds, such as AZT and Poly-I:C for the treatment of retroviruses. Also disclosed are novel polyoxoanions.
REFERENCES:
Domaille, J. Am. Chem. Soc., 1984, 106, 7677-7687, "1-and 2-Dimensional Tungsten-183 and Vanadium-51 NMR Characterization of Isopolymetalates and Heteropolymetalates".
Domaille et al, J. Am. Chem. Soc., 1986, 108, 2108-2109, "Synthesis and Structural Characterization of the First Phosphorous-Centered Baker-Figgis-.gamma.-Dodecametalate: .gamma.Cs.sub.5 [PV.sub.2 W.sub.10 O.sub.40 ].multidot..times.H.sub.2 O".
Altenars et al, Inorganic Chemistry, vol. 14, No. 2, 1975, pp. 417-421, "Models for Heteropoly Blues, Degrees of Valence Trapping in Vanadium (IV)-and Molybdenum(V)-Substituted Keggin Anions".
Blasecki John W.
Domaille Peter J.
Du Pont Merck Pharmaceutical Company
Nutter Nathan M.
LandOfFree
Inhibition of HIV and other retroviruses by polyoxoanions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of HIV and other retroviruses by polyoxoanions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of HIV and other retroviruses by polyoxoanions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-272279